Education
About Us
Working with TipRanks
Follow Us
Athersys (ATHXQ)
OTHER OTC:ATHXQ
ATHXQ Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $1.64
Previous CloseN/A
Volume42.00
Average Volume (3M)N/A
Market Cap
$62.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-408.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding61,718,765
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ATHXQ FAQ
What was Athersys’s price range in the past 12 months?
Athersys lowest stock price was <$0.01 and its highest was $1.64 in the past 12 months.
What is Athersys’s market cap?
Athersys’s market cap is $62.00.
When is Athersys’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Athersys’s earnings last quarter?
Currently, no data Available
Is Athersys overvalued?
According to Wall Street analysts Athersys’s price is currently Overvalued.
Does Athersys pay dividends?
Athersys does not currently pay dividends.
What is Athersys’s EPS estimate?
Athersys’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Athersys have?
Athersys has 61,718,765 shares outstanding.
What happened to Athersys’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Athersys?
Currently, no hedge funds are holding shares in ATHXQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Athersys
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
Salarius Pharmaceuticals
―
Scinai Immunotherapeutics
―
Dermata Therapeutics
―
Bluejay Diagnostics
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.03% Other Institutional Investors
99.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---